---
title: "The pharmaceutical sector rises, with multiple stocks hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233548434.md"
description: "The pharmaceutical sector surged, with multiple stocks such as BHC, HC CHEMICAL, and Rundu Pharma hitting the daily limit. ApicHope and Mabwell rose over 8%, while KHPG increased by more than 7%"
datetime: "2025-03-28T02:03:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233548434.md)
  - [en](https://longbridge.com/en/news/233548434.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233548434.md)
generator: "portal-rs"
---

# The pharmaceutical sector rises, with multiple stocks hitting the daily limit

The pharmaceutical sector surged, with multiple stocks such as BHC, HC CHEMICAL, and Rundu Pharma hitting the daily limit. ApicHope and Mabwell rose over 8%, while KHPG increased by more than 7%

### Related Stocks

- [600721.CN](https://longbridge.com/en/quote/600721.CN.md)
- [000953.CN](https://longbridge.com/en/quote/000953.CN.md)
- [002923.CN](https://longbridge.com/en/quote/002923.CN.md)
- [300723.CN](https://longbridge.com/en/quote/300723.CN.md)
- [688062.CN](https://longbridge.com/en/quote/688062.CN.md)
- [002773.CN](https://longbridge.com/en/quote/002773.CN.md)

## Related News & Research

- [Mabwell passes Brazil ANVISA GMP inspection for denosumab biosimilars](https://longbridge.com/en/news/295337739.md)
- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/296117308.md)
- [PXT: Production guidance nearly doubles for H2 2026, driven by acquisitions and exploration success](https://longbridge.com/en/news/296393798.md)
- [FOCUS-As Europe rearms, Italy's fragmented space sector faces a scale test](https://longbridge.com/en/news/296303505.md)
- [Elon Musk Says China Is ‘By Far’ Strongest AI Competitor, Echoing 2011 Warning as SPCX Faces New Rocket Rival](https://longbridge.com/en/news/296455841.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**